Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus

BACKGROUND: Recently, basic and clinical studies have provided evidence supporting the relationship between circulating levels of fibroblast growth factor (FGF) 23 and the development of atherosclerosis. Given that diabetes is an established risk factor for lower extremity atherosclerotic disease (L...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xingxing, Hu, Xiang, Ma, Xiaojing, Su, Hang, Ying, Lingwen, Peng, Jiahui, Pan, Xiaoping, Bao, Yuqian, Zhou, Jian, Jia, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472967/
https://www.ncbi.nlm.nih.gov/pubmed/28619026
http://dx.doi.org/10.1186/s12933-017-0559-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472967/
https://www.ncbi.nlm.nih.gov/pubmed/28619026
http://dx.doi.org/10.1186/s12933-017-0559-x

Ejemplares similares